Frontiers in pharmacology · 2026
Benzofuran compound from Sophora tonkinensis Gagnep suppresses nasopharyngeal carcinoma growth via PI3K/AKT/mTOR pathway: evidence from molecular dynamics simulation and in vitro experiments.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wu Peiying, Gong Xiaomei, Zhang Wenyu, Mo Dandan, He Lili, Song Zhijun, Ou Chunli, Li Meng, Zhou Xiaolei, Xiao Xingyu, Xia Xianghua, Wang Shuo
Аннотация
INTRODUCTION: Shandougen (SDG), the dried root and rhizome of Sophora tonkinensis Gagnep., has been historically documented in Ben Cao Qiu Zhen for its properties of "clearing heat, detoxifying, reducing swelling, and relieving throat disorders." It is highly valued as a primary herb for relieving throat swelling and abscesses. SDG-based formulas, such as "Bi Yan Ling Tablets" and the "Bi'ai Formula," have shown definite efficacy against heat-toxin accumulation type nasopharyngeal carcinoma (NPC). Despite this, the specific active monomer in SDG inhibiting NPC remains unclear, warranting further investigation.
OBJECTIVE: This study aimed to identify the bioactive monomers underlying SDG's anti-NPC efficacy and elucidate their molecular mechanisms.
METHODS: Guided by HPLC fingerprinting, targeted isolation and purification of components from the active fraction were performed. 13 compounds were screened for activity, with benzofuran compound 2-(2',4'-dihydroxyphenyl)-5,6-methylenedioxybenzofuran (ABF) showing the most potent in vitro effects. Molecular dynamics (MD) simulations were employed to evaluate the binding affinity and stability of ABF with the target protein. The anti-proliferative mechanisms of ABF were investigated in cells, and its anti-tumor capacity was evaluated using a nude mouse xenograft model.
RESULTS: ABF exhibited stronger anti-proliferative activity against CNE1 and CNE2 cells compared to SDG extract, with a 10-fold lower 48-h IC50 value. ABF inhibits the invasion and metastasis of NPC cells, which is associated with S-phase cell cycle arrest and the downregulation of cyclin E1 and CDK2 proteins. Apoptosis induction by ABF was associated with increased caspase family proteins and lowered the Bcl-2/Bax ratio. PCR and Western blot analyses confirmed that ABF is involved in the downregulation of the PI3K/AKT/mTOR pathway, inhibiting NPC cell growth. Additionally, in a nude mouse xenograft model, ABF treatment at high doses achieved tumor inhibition rates of 46.59% and 45.71%, respectively,and the expression of the tumor proliferation marker KI67 was significantly reduced.
CONCLUSION: ABF demonstrates promising anti-NPC potential, providing scientific evidence for the traditional anti-cancer use of SDG. This molecule may serve as a natural lead compound for NPC growth inhibitors.
OBJECTIVE: This study aimed to identify the bioactive monomers underlying SDG's anti-NPC efficacy and elucidate their molecular mechanisms.
METHODS: Guided by HPLC fingerprinting, targeted isolation and purification of components from the active fraction were performed. 13 compounds were screened for activity, with benzofuran compound 2-(2',4'-dihydroxyphenyl)-5,6-methylenedioxybenzofuran (ABF) showing the most potent in vitro effects. Molecular dynamics (MD) simulations were employed to evaluate the binding affinity and stability of ABF with the target protein. The anti-proliferative mechanisms of ABF were investigated in cells, and its anti-tumor capacity was evaluated using a nude mouse xenograft model.
RESULTS: ABF exhibited stronger anti-proliferative activity against CNE1 and CNE2 cells compared to SDG extract, with a 10-fold lower 48-h IC50 value. ABF inhibits the invasion and metastasis of NPC cells, which is associated with S-phase cell cycle arrest and the downregulation of cyclin E1 and CDK2 proteins. Apoptosis induction by ABF was associated with increased caspase family proteins and lowered the Bcl-2/Bax ratio. PCR and Western blot analyses confirmed that ABF is involved in the downregulation of the PI3K/AKT/mTOR pathway, inhibiting NPC cell growth. Additionally, in a nude mouse xenograft model, ABF treatment at high doses achieved tumor inhibition rates of 46.59% and 45.71%, respectively,and the expression of the tumor proliferation marker KI67 was significantly reduced.
CONCLUSION: ABF demonstrates promising anti-NPC potential, providing scientific evidence for the traditional anti-cancer use of SDG. This molecule may serve as a natural lead compound for NPC growth inhibitors.